Osiris Therapeutics, Inc. · Columbia, MD United States (NASDAQ: OSIR)
| 7015 Albert Einstein Dr. | Phone: 443-545-1800 |
| Columbia, MD | Fax: 443-545-1701 |
| 21046 | |
| United States | 
Map This Company |
Osiris Therapeutics, Inc. Rankings
More Companies in These Related Industries: Biologics MfgCompany Description
Unlike the Eygptian god, this Osiris seeks to keep people out of the afterlife. Osiris Therapeutics uses donated bone marrow stem cells to develop its drug candidates. Its lead candidate, Prochymal, is in clinical trials as a possible treatment for Crohn's disease and graft-vs.-host disease. The drug is also being investigated for use in prolonging insulin production in early onset diabetes patients and to restore cardiac functioning following a heart attack. Its second drug candidate, Chondrogen, is in clinical trials to treat osteoarthritis in the knee. Chairman Peter Friedli holds more than 40% of the company's stock.
Osiris Therapeutics, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: OSIR Single Location |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 59 |
Executives
17 executives listed for Osiris Therapeutics, Inc.'s Columbia, MD location.
| Chairman | Peter Friedli | |
|---|---|---|
| President, CEO, and Director | C. Randal Mills | |
| CFO, Treasurer, and Secretary | Philip Jacoby |